Short answer
Fertility treatment programs mandate STI screening for both partners before procedures. Protecting gametes, pregnancies, newborns, and laboratory staff through verified infection-free baselines.
Panels run early because treatment and retesting consume calendar time that stimulation schedules cannot spare later.
A positive finding delays procedures; it does not end fertility prospects, and prompt treatment usually restores timelines quickly.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →The workup sequence
- Both-partner panels at program entry. Chlamydia, gonorrhea, HIV, syphilis, hepatitis per protocol.
- Treatment of findings with guideline-based regimens and documented clearance.
- Retesting where required. Test-of-cure or window completion before procedures proceed.
- Ongoing protection through treatment cycles. New infections mid-protocol waste enormous investment.
Conception-side view: STI Testing When Trying to Conceive.
Testing-versus-fertility distinction: The Difference Between STI Testing and Fertility Testing.
Timing wisdom
- Screen at workup start, never mid-cycle when findings force cancellations.
- Treat immediately on positives. Every cleared week preserves downstream scheduling.
- Protect throughout. Condoms through treatment cycles guard the investment.
- Document everything. Programs run on paperwork; complete records prevent repeat testing.
Program requirement navigation
Fertility programs’ infectious-disease requirements vary in scope and stringency. Understand your specific program’s panel, timing rules, retest triggers, and documentation standards early enough to complete everything without cycle delays.
Requirement checklists obtained at workup start prevent last-minute scrambles derailing expensive stimulations.
Coordinate requirements across providers efficiently: primary results shared to fertility clinics promptly, repeat draws batched with cycle monitoring bloodwork where possible, and partner compliance tracked jointly rather than assumed.
Administrative excellence here protects five-figure treatment investments from four-figure testing oversights.
Treat requirements as project management with medical content.
LGBTQ+ fertility pathways
LGBTQ+ fertility journeys involve distinctive infectious-disease considerations: donor gamete screening protocols (rigorous, regulated, program-managed), reciprocal IVF partner screening (both partners regardless of gamete roles), surrogacy arrangements adding carrier screening layers, and chosen-family support structures navigating heteronormative systems.
Competent programs address all dimensions affirmatively.
Provider selection matters enormously: explicitly LGBTQ-competent fertility practices versus tolerant-but-inexperienced ones produce different experiences and sometimes different outcomes.
Community referrals identify genuinely affirming programs reliably; intake-form language previews cultures accurately.
Fertility care is intimate healthcare. Affirmation quality affects medical quality through disclosure completeness and trust depth.
When to seek care
Now for baseline testing after any fresh exposure or symptom onset; on schedule as windows close; and immediately for pregnancy concerns, assault, severe pain, or known positive-partner exposure.